European Crystallography Meeting delegates Raise Money for Charity
News Oct 02, 2013
The ECMs are the general meetings of the European Crystallographic Association (ECA) and ECM28 was held in the UK at the University of Warwick from 25-29 August 2013. At the meeting, crystallographers and researchers with interests in crystallography and crystal growth met to share their scientific views and new achievements.
Rigaku Corporation was a proud corporate sponsor of the ECM, and organized an initiative to raise money for a chosen charity, Cancer Research UK. For the event, stationary exercise bikes were used to cycle the 1376km straight-line distance from Warwick, UK to the location of the next ECM in Rovinj, Croatia in 2015.
Teams from Rigaku UK and Rigaku Europe SE in Germany attended the event, representing both materials and protein crystallography. For every kilometer cycled, Rigaku donated £1 and prizes were given to those who pedaled the most distance. At the conference, 66 ECM delegates participated and raised a total of £1376 for Cancer Research UK. “To be perfectly honest, we hadn’t realized how popular and competitive the bikes would be and doubted that we would succeed in completing the distance required to reach the distant shores of Croatia. However, fierce efforts by the group at Southampton, got us on our way very quickly. Word got round, and soon everyone wanted a shot at outdoing their contemporaries,” commented Dr. Mark Benson who originated the idea.
Among the top cyclists were Fabiola Sanjuan-Szkiorz and Slawomir Domagala from the University of Warsaw with 100km each and Prof. William Clegg from the University of Newcastle with 88km pedaled. The 29th European Crystallography Meeting will be held in Rovinj, Croatia from 23-28 August 2015.
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE
Marburg Virus: Workings of the First Promising Treatment RevealedNews
Scientists have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.READ MORE
Plant Protein Reveals Surprising Immune Response to Bacterial AttackNews
When you see brown spots on otherwise healthy green leaves, you may be witnessing a plant’s immune response as it tries to keep a bacterial infection from spreading. Some plants are more resistant to such infections than others, and plant biologists want to understand why. Scientists studying a plant protein called SOBER1 recently discovered one mechanism by which, counter-intuitively, plants seem to render themselves less resistant to infection.READ MORE